Paper41001838
Comprehensive Pan-Cancer Analysis of TRNT1 as a Potential Biomarker for Breast Cancer.
Li X and 2 others. J Cell Mol Med, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Comprehensive Pan-Cancer Analysis of TRNT1 as a Potential Biomarker for Breast Cancer. Papers, record 41001838. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41001838
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Biomarkers, Tumor | Major topic |
| Humans | |
| Female | |
| Gene Expression Regulation, Neoplastic | |
| Prognosis | |
| DNA Methylation | |
| Cell Proliferation | |
| Computational Biology | |
| Promoter Regions, Genetic | |
| Apoptosis | |
| Cell Line, Tumor | |
| Gene Expression Profiling |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82003149 | the National Natural Science Foundation of China | PubMed | ||
| KY012023289 | The Research Foundation for Advanced Talents of Guangdong Provincial People's Hospital | PubMed | ||
| 2025A1515010446 | Natural Science Foundation of Guangdong Province, China | PubMed | ||
| 2023B110008 | Guangdong Provincial Clinical Research Center for Laboratory Medicine | PubMed |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40351118 | CD8+ T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevance. | Oncoimmunology | 2025 | https://conductscience.org/library/papers/40351118 | PubMed |
| 2 | 11709054 | Mechanisms of p53-dependent apoptosis. | Biochem Soc Trans | 2001 | https://conductscience.org/library/papers/11709054 | PubMed |
| 3 | 38571942 | Activated B-Cells enhance epitope spreading to support successful cancer immunotherapy. | Front Immunol | 2024 | https://conductscience.org/library/papers/38571942 | PubMed |
| 4 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 5 | 25652405 | The 3' addition of CCA to mitochondrial tRNASer(AGY) is specifically impaired in patients with mutations in the tRNA nucleotidyl transferase TRNT1. | Hum Mol Genet | 2015 | https://conductscience.org/library/papers/25652405 | PubMed |
| 6 | 10228556 | Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. | Cell Mol Life Sci | 1999 | https://conductscience.org/library/papers/10228556 | PubMed |
| 7 | 31342438 | The Implication of mRNA Degradation Disorders on Human DISease: Focus on DIS3 and DIS3-Like Enzymes. | Adv Exp Med Biol | 2019 | https://conductscience.org/library/papers/31342438 | PubMed |
| 8 | 34159625 | Contribution of upregulated aminoacyl-tRNA biosynthesis to metabolic dysregulation in gastric cancer. | J Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/34159625 | PubMed |
| 9 | 39329702 | Characterizing the Tumor Microenvironment and Its Prognostic Impact in Breast Cancer. | Cells | 2024 | https://conductscience.org/library/papers/39329702 | PubMed |
| 10 | 39456618 | The Diversity of Methylation Patterns in Serous Borderline Ovarian Tumors and Serous Ovarian Carcinomas. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39456618 | PubMed |
| 11 | 21152119 | S-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer. | Int J Biol Sci | 2010 | https://conductscience.org/library/papers/21152119 | PubMed |
| 12 | 22276153 | Differential gene expression between African American and European American colorectal cancer patients. | PLoS One | 2012 | https://conductscience.org/library/papers/22276153 | PubMed |
| 13 | 25193871 | Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD). | Blood | 2014 | https://conductscience.org/library/papers/25193871 | PubMed |
| 14 | 31597272 | MicroRNAs and Epigenetics Strategies to Reverse Breast Cancer. | Cells | 2019 | https://conductscience.org/library/papers/31597272 | PubMed |
| 15 | 29945573 | Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations. | BMC Cancer | 2018 | https://conductscience.org/library/papers/29945573 | PubMed |
| 16 | 25613900 | Proteomics. Tissue-based map of the human proteome. | Science | 2015 | https://conductscience.org/library/papers/25613900 | PubMed |
| 17 | 40721005 | Transforming the "cold" tumors to "hot" tumors: strategies for immune activation. | Biochem Pharmacol | 2025 | https://conductscience.org/library/papers/40721005 | PubMed |
| 18 | 25962426 | Phase I/II study of temsirolimus for patients with unresectable Hepatocellular Carcinoma (HCC)- a correlative study to explore potential biomarkers for response. | BMC Cancer | 2015 | https://conductscience.org/library/papers/25962426 | PubMed |
| 19 | 26508480 | Targeting epigenetic regulations in cancer. | Acta Biochim Biophys Sin (Shanghai) | 2016 | https://conductscience.org/library/papers/26508480 | PubMed |
| 20 | 29751559 | Insights of Crosstalk between p53 Protein and the MKK3/MKK6/p38 MAPK Signaling Pathway in Cancer. | Cancers (Basel) | 2018 | https://conductscience.org/library/papers/29751559 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41001838 | Comprehensive Pan-Cancer Analysis of TRNT1 as a Potential Biomarker for Breast Cancer. | J Cell Mol Med | 2025 | https://conductscience.org/library/papers/41001838 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
| TRNT1 | 51095 | PubTator's text mining | https://conductscience.org/library/genes/51095 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41001838
GET https://conductscience.org/api/papers/v1/41001838/references?page=2